Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

NCT06565364 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06565364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
January 7, 2019
Completion date
March 31, 2023
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibodies drug specific, thrombocytopenia